Apixaban: Low-Dose Long-Term Use After Provoked VTE Shows Benefits
Christopher Cannon, Editor in Chief, Harvard Health Publishing, shared a post on LinkedIn:
“Low-dose Apixaban long-term following a “provoked” VTE is beneficial.
I think that practice will change – from stopping anticoagulation after a period of initial treatment, to reducing to 1/2 dose for long-term prevention.
This has been my practice for “unprovoked” DVT/PE based on a host of other trials, but this study now extends this: it looked at those with a transient factor like surgery, trauma or immobility – but with an enduring risk factor: ASCVD, Obesity, Heart failure (systolic, diastolic, or combined, lung disease(COPD, asthma, interstitial lung disease), Chronic kidney disease (eGFR <60 mL/min/1.72m2)
Chronic inflammatory/autoimmune disorder (inflammatory arthritis, vasculitis, inflammatory bowel disease, chronic infection) or Persistent immobility. That covers a lot of patients.
Younger, healthy patients who have “provoked” VTE. e.g., post surgery or immobility- they would be ones where stopping after an initial period of anticoagulation is reasonable.
Congratulations Gregory Piazza, Samuel Z. Goldhaber, MD and colleagues!”
Read full article here.
Title: Apixaban for Extended Treatment of Provoked Venous Thromboembolism
Authors: Gregory Piazza, Behnood Bikdeli, Arvind K. Pandey, Darsiya Krishnathasan, Candrika D. Khairani, Antoine Bejjani, Ruth H. Morrison

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation
-
Nov 8, 2026, 05:34Eugene Bolotin: Thrombosis and Survival in Pancreatic Cancer
-
Nov 8, 2026, 05:24Recognising Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding – RPTH Journal
-
Nov 8, 2026, 05:11WFH CCS 2027 Abstract Submission Now Open – World Federation of Hemophilia